What is Prostate Cancer Phase II PD 0332991 Clinical Trial?

Category: Others

false

A Randomized Phase II Study of Androgen Deprivation Therapy With or Without PD 0332991 (pablociclib) in RB-Positive Metastatic Hormone-Sensitive Prostate Cancer. NCT02059213

Why patients stopped taking Prostate Cancer Phase II PD 0332991 Clinical Trial

Multiple reasons could be selected

Reason Patients
Did not seem to work 1
See 1 patient who's stopped using Prostate Cancer Phase II PD 0332991 Clinical Trial

Duration

Stopped using Prostate Cancer Phase II PD 0332991 Clinical Trial

Duration Patients
1 - 6 months 1
Last updated:
There are no evaluations for Prostate Cancer Phase II PD 0332991 Clinical Trial.